1. Home
  2. AUPH vs DCO Comparison

AUPH vs DCO Comparison

Compare AUPH & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.20

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$96.55

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUPH
DCO
Founded
1993
1849
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
AUPH
DCO
Price
$15.20
$96.55
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$17.25
$117.80
AVG Volume (30 Days)
1.1M
94.9K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$265,808,000.00
$806,224,000.00
Revenue This Year
$21.76
$6.11
Revenue Next Year
$16.45
$8.03
P/E Ratio
$28.99
N/A
Revenue Growth
20.62
3.17
52 Week Low
$6.55
$51.76
52 Week High
$16.54
$101.47

Technical Indicators

Market Signals
Indicator
AUPH
DCO
Relative Strength Index (RSI) 43.08 57.12
Support Level $15.64 $94.00
Resistance Level $15.98 $99.23
Average True Range (ATR) 0.39 2.48
MACD -0.13 0.14
Stochastic Oscillator 13.73 59.52

Price Performance

Historical Comparison
AUPH
DCO

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

Share on Social Networks: